GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » Cash, Cash Equivalents, Marketable Securities

22nd Century Group (22nd Century Group) Cash, Cash Equivalents, Marketable Securities

: $2.06 Mil (As of Dec. 2023)
View and export this data going back to 2011. Start your Free Trial

22nd Century Group's quarterly cash, cash equivalents, marketable securities declined from Jun. 2023 ($4.43 Mil) to Sep. 2023 ($2.85 Mil) but then stayed the same from Sep. 2023 ($2.85 Mil) to Dec. 2023 ($2.06 Mil).

22nd Century Group's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($48.74 Mil) to Dec. 2022 ($20.40 Mil) and declined from Dec. 2022 ($20.40 Mil) to Dec. 2023 ($2.06 Mil).


22nd Century Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for 22nd Century Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

22nd Century Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.96 22.34 48.74 20.40 2.06

22nd Century Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.40 16.23 4.43 2.85 2.06

22nd Century Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


22nd Century Group  (NAS:XXII) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


22nd Century Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of 22nd Century Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


22nd Century Group (22nd Century Group) Business Description

Industry
Traded in Other Exchanges
N/A
Address
500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.
Executives
Andrew Arno director C/O MERRIMAN CURHAN FORD GROUP, INC., 600 CALIFORNIA STREET, 9TH FLOOR, SAN FRANCISCO CA 94108
James A Mish director, officer: Chief Executive Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino officer: Chief Administrative Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Peter Ferola officer: Chief Legal Officer BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
John J Miller officer: President, Tobacco 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany director C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Michael Zercher officer: Chief Operating Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Robert Hugh Kinsman officer: Chief Financial Officer 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet director 6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald officer: Chief Financial Officer C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson director C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Richard M. Sanders director 1119 PIEDRA RONDO, SANTA FE NM 87501
Roger D O'brien director C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Koganov director 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Nora B Sullivan director C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203